Customers of genetic data outfit 23andMe may be at greater risk than they realize, suggests a New York Times story that argues the company’s woes could be short-lived compared to the possible danger facing those roughly 15 million people if 23andMe can’t continue as a going concern. Certainly, with each passing day, the hope of […]
© 2024 TechCrunch. All rights reserved. For personal use only.
Source: TechCrunch 23andMe’s future prompts more worries, as genomic data analysis improves